Current activities at the Centers for Disease Control and Prevention's National Diabetes Laboratory

In 1997, the Centers for Disease Control and Prevention established the National Diabetes Laboratory in order to help prevent and treat type 1 diabetes. This state-of-the-art laboratory collaborates with research scientists and key national and international organizations throughout the world to identify and study risk factors for type 1 diabetes by developing measurements for glycosylated proteins, developing and evaluating technology for measuring genetic risk factors for the disease, and working to standardize autoantibody measurements. Developing improved technologies for diagnosing and managing diabetes and developing reference materials for properly calibrating and standardizing blood glucose meters are also critical aspects of the laboratory's work. In addition, the laboratory provides quality storage for valuable collections of biologics and other materials and facilitates sharing of specimens, associated epidemiologic data, and test results. Working with our partners in diabetes research, we are improving the diagnosis, treatment, and prevention of type 1 diabetes.     

The infection control information system of the Hospital Infections Program, Centers for Disease Control and Prevention

In December 1990 the Investigation and Prevention Branch, Hospital Infections Program, Centers for Disease Control and Prevention (CDC), developed the Hospital Infections Program infection control information system (HIP ICIS) to respond more efficiently to more than 200 public inquiries (telephone or written) that HIP receives daily. The HIP ICIS allows anyone with a Touch-Tone telephone, fax machine, or computer to access CDC information that answers the most commonly asked questions from infection control practitioners and other health care workers. The HIP ICIS has received approximately 56,608 inquiries; of these, 33% were about CDC guidelines on prevention and control of nosocomial infections, 25% about issues related to HIV, 16% about sterilization and disinfection of medical devices, 8% about methicillin-resistant Staphylococcus aureus, 3% about long-term care facilities, and 17% about miscellaneous topics (e.g., nosocomial infection rates, infection control courses, and ventilation, construction, and renovation of hospitals). The HIP ICIS is an efficient method of providing infection control guidance to the infection control community. In this article, we a) review the history of the HIP ICIS, b) present data on HIP ICIS usage, c) summarize the current HIP ICIS contents, and d) present step-by-step instructions on how to access the HIP ICIS.     

Cost-effective application of the Centers for Disease Control Guideline for Prevention of Nosocomial Pneumonia

Some parts of the Guideline are clearly cost-effective. Abandoning routine cultures of respiratory therapy equipment is cost-effective and should be adopted by any hospitals that have not done so already. Other practices such as the use of preoperative and postoperative instructions regarding deep breathing and incentive spirometry, and the policy of never reusing respiratory therapy equipment items that are intended for single use probably warrant further cost-benefit analysis. Finally, there is increasing evidence that changing ventilator tubing every 24 hours is not cost-effective. Changing tubing every 48 hours appears to be safe and can save hospitals substantial sums of money.     

National nosocomial infections surveillance system (NNIS): description of surveillance methods.

The National Nosocomial Infections Surveillance System (NNIS) is an ongoing collaborative surveillance system sponsored by the Centers for Disease Control (CDC) to obtain national data on nosocomial infections. The CDC uses the data that are reported voluntarily by participating hospitals to estimate the magnitude of the nosocomial infection problem in the United States and to monitor trends in infections and risk factors. Hospitals collect data by prospectively monitoring specific groups of patients for infections with the use of protocols called surveillance components. The surveillance components used by the NNIS are hospitalwide, intensive care unit, high-risk nursery, and surgical patient. Detailed information including demographic characteristics, infections and related risk factors, pathogens and their antimicrobial susceptibilities, and outcome, is collected on each infected patient. Data on risk factors in the population of patients being monitored are also collected; these permit the calculation of risk-specific rates. An infection risk index, which includes the traditional wound class, is being evaluated as a predictor of the likelihood that an infection will develop after an operation. A major goal of the NNIS is to use surveillance data to develop and evaluate strategies to prevent and control nosocomial infections. The data collected with the use of the surveillance components permit the calculation of risk-specific infection rates, which can be used by individual hospitals as well as national health-care planners to set priorities for their infection control programs and to evaluate the effectiveness of their efforts. The NNIS will continue to evolve in finding more effective and efficient ways to assess the influence of patient risk and changes in the financing of health care on the infection rate.     

Evolution of hospital participation in the National Nosocomial Infections Surveillance System, 1986 to 1993

Objective: To study changes in the use of National Nosocomial Infections Surveillance System (NNIS) surveillance components since 1986 that could reflect an evolution in the way in which NNIS hospitals conduct surveillance of nosocomial infections.Method: We analyzed NNIS data from 1986 to 1993 collected at the 199 US hospitals that participated in the NNIS system during this period.Results: The number of hospitals participating in the NNIS system increased threefold between 1986 and 1993. A parallel increase was noticed in the amount of surveillance data for all NNIS components except for the hospital-wide component. The percentage of all hospitals reporting at least 1 calendar month per year of data from the hospital-wide component decreased from 95% in 1986 to 37% in 1993. During this period, use of the hospital-wide component was greater among the hospitals whose first participation in the NNIS system occurred before 1987.Conclusion: Interest by NNIS hospitals in the hospital-wide component apparently decreased between 1987 and 1993. In contrast, the interest in NNIS components that allow calculation of risk-adjusted nosocomial infection rates (intensive care unit, high-risk nursery, and surgical patient components) increased dramatically after 1986. This increased interest in surveillance with NNIS components that allow risk adjustment and interhospital comparison of infection rates suggests that the feasibility of collection of and interest in such data are high.     

Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999

The National Nosocomial Infections Surveillance (NNIS) system is the oldest and largest monitoring system for health care-acquired infections in the United States. This report describes both the characteristics of NNIS hospitals compared with those of US hospitals with 100 beds or more and their infection control programs. Overall, NNIS hospitals tend to have more hospital beds than the average for-comparable US hospitals. The majority of NNIS hospitals have affiliations with academic medical centers, and most have substantial intensive care units. Even though infection control professionals in NNIS hospitals spend most of their time in inpatient settings, 40% of their time is also spent in a variety of other settings, including home health, outpatient surgery or clinics, extended care facilities, employee health and quality management, and other clinical or administrative activities. As described in this report, the infrastructure of the NNIS system offers a national resource on which to build improved voluntary patient safety monitoring efforts, as outlined in the recent Institute of Medicine report on medical errors.     

Cost-effective application of the Centers for Disease Control Guideline for Prevention of Surgical Wound Infections

Surgical wound infections present a serious hazard to patients and an important legal and economic liability to health care providers. This Guideline furnishes infection control practitioners with several excellent cost-saving concepts and, if implemented, would result in a reduction in the rates of surgical wound infections.     

CDC gives communities prevention strategies. Centers for Disease Control and Prevention

Government officials say that widespread HIV prevention efforts are needed among injection drug users. This group, along with their sexual partners and children, account for one-third of all reported AIDS cases in the United States. The Centers for Disease Control and Prevention (CDC) issued community guidelines in 1997 for stopping the spread of HIV through injection drug use. These guidelines include changing community laws to permit the purchase of clean syringes, and using substance abuse intervention programs to provide education on risks associated with drug use and sexual behavior. The CDC also stressed the need for a Federal commitment to drug treatment programs.